Drug Type Small molecule drug |
Synonyms- |
Action inhibitors |
Mechanism IL-13 inhibitors(Interleukin-13 inhibitors), IL-6 inhibitors(Interleukin-6 inhibitors), NLRP3 inhibitors(NACHT, LRR and PYD domains-containing protein 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alzheimer Disease | Discovery | - | 11 Feb 2026 | |
| Cardiovascular Diseases | Discovery | - | 11 Feb 2026 | |
| Endocrinology and Metabolic Disease | Discovery | - | 11 Feb 2026 | |
| Inflammatory Bowel Diseases | Discovery | - | 11 Feb 2026 | |
| Neoplasms | Discovery | - | 11 Feb 2026 | |
| Other Diseases | Discovery | - | 11 Feb 2026 | |
| Renal Insufficiency | Discovery | - | 11 Feb 2026 |





